AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
As of today, AstraZeneca(AZN) shares are valued at $181.24. The company's market cap stands at 281.08B, with a P/E ratio of 27.37 and a dividend yield of 1.7%.
On 2026-05-05, AstraZeneca(AZN) stock moved within a range of $180.00 to $181.96. With shares now at $181.24, the stock is trading +0.7% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 2.46M, compared to an average daily volume of 2.34M.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $132.32.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $132.32.
AZN News
AstraZeneca plc ((GB:AZN)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and p...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper de...
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisio...
Analyst ratings
81%
of 31 ratingsMore AZN News
Earnings season is in full swing, and on April 29, three Big Pharma mainstays reported Q1 2026 earnings. Investors were looking for strong results—and strong gu...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
FDA Panel Backs Truqap In Prostate Cancer The FDA panel voted 7-1, with one abstention, recognizing a favorable benefit-risk profile for AstraZeneca's Truqap (...
The offices of AstraZeneca in England. The FDA isn’t bound by the committee’s vote, but its takes its advice into consideration. Paul Ellis / Agence France-Pres...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
The company states: “The US Food and Drug Administration’s Oncologic Drugs Advisory Committee has recognised a favorable benefit risk profile for AstraZeneca’s...
Jefferies analyst Michael Leuchten maintained a Buy rating on AstraZeneca today and set a price target of p18,000.00. Claim 55% Off TipRanks Unlock hedge fund-l...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.